Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 2;16(3):3690–3698. doi: 10.3892/ol.2018.9055

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Chen et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 4. — TS and TACE-only treatments do not decrease the diameter of portal vein and its branches. (A) Portal vein and (B) portal vein branches in the TS group. (C) Portal vein and (D) portal vein branches in the TACE group. (E-G) MRI prior to administration of sorafenib. (H-J) MRI subsequent to administration of sorafenib. E, H, F, I, G and J represent the same patient prior and after adminstration of sorafenib respectively. TACE, transarterial chemoembolization; TS group, TACE combined with sorafenib. The magnification for all images in Figure 4 is 1:4.